ArticleInternational journal of oral science2026
Correction: Antisense oligonucleotide targeting TARDBP-EGFR splicing axis inhibits progression of oral squamous cell carcinoma through ABCA1-regulated cholesterol efflux.
Nan Ni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.